Search Results - "Casado, A. Ruiz"

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients by Toledano-Fonseca, M., Gómez-España, M.A., Élez, E., Grávalos, C., García-Alfonso, P., Rodríguez, R., Losa, F., Alés Díaz, I., Graña, B., Valladares-Ayerbes, M., García-Ortiz, M.V., Polo, E., Salgado, M., Rivera, F., Safont, M.J., Salud, A., Ruiz-Casado, A., Tabernero, J.M., Riesco, M.C., Rodríguez-Ariza, A., Aranda, E.

“…The benefit of adding the antiangiogenic drug aflibercept to FOLFIRI regime in metastatic colorectal cancer (CRC) patients resistant to or progressive on an…”
Get full text

Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Randomized Trial by ALBEROLA, V, CAMPS, C, GONZALEZ-LARRIBA, J. L, DIZ, P, CARDENAL, F, ARTAL, A, CARRATO, A, MORALES, S, SANCHEZ, J. J, DE LAS PENAS, R, FELIP, E, LOPEZ-VIVANCO, G, PROVENCIO, M, ISLA, D, ROSELL, R, VADELL, C, BOVER, I, RUIZ-CASADO, A, AZAGRA, P, JIMENEZ, U

“…To compare the survival benefit obtained with cisplatin plus gemcitabine, a cisplatin-based triplet, and nonplatinum sequential doublets in advanced…”
Get full text

Validity of the Physical Activity Questionnaires IPAQ-SF and GPAQ for Cancer Survivors: Insights from a Spanish Cohort by Ruiz-Casado, A, Alejo, L B, Santos-Lozano, A, Soria, A, Ortega, M J, Pagola, I, Fiuza-Luces, C, Palomo, I, Garatachea, N, Cebolla, H, Lucia, A

“…Regular physical activity (PA) decreases mortality risk in survivors of breast and colorectal cancer. Such impacts of exercise have prompted initiatives…”
Get more information

O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer by Van Cutsem, E., Taieb, J., Yaeger, R., Yoshino, T., Maiello, E., Elez, E., Dekervel, J., Ross, P., Ruiz Casado, A., Graham, J., Kato, T., Ruffinelli, J., André, T., Carriere Roussel, E., Klauck, I., Groc, M., Grothey, A., Vedovato, J., Tabernero, J.

Get full text

Orbital metastasis from oesophageal cancer. When the ophtalmologist meets gastrointestinal specialists by Ruiz-Casado, A., Hijos, M., Ruiz, R., Romero, J.

Get full text

Interim quality of life results from a real world European survey on the unmet needs of patients living with metastatic colorectal cancer (mCRC) by Maravic, Z., Wyrwicz, L., Karczmarek-Borowska, B., Horvath, A., Ruiz Casado, A., Carrato Mena, A., Muszbek, N., Rakonczai, P.

Get full text

Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting by Franco, F., Camara, J. C., Martín-Valadés, J. I., López-Alfonso, A., Marrupe, D., Gutiérrez-Abad, D., Martínez-Amores, B., León, A., Juez, I., Pérez, M., Royuela, A., Ruiz-Casado, A.

“…Background/objectives The incidence of pancreatic cancer is increasing in developed countries. The incorporation of new therapies, to the first-line treatment…”
Get full text

LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer by Grothey, A., Tabernero, J., Taieb, J., Yaeger, R., Yoshino, T., Maiello, E., Fernandez, E. Elez, Casado, A. Ruiz, Ross, P., André, T., Kato, T., Ruffinelli, J., Graham, J., den Eynde, M. Van, Vera, R., Jean, B., Roussel, E. Carriere, Cahuzac, C., Issiakhem, Z., Vedovato, J., Cutsem, E. Van

Get full text

Recruitment for a survey on the unmet needs of patients living with metastatic colorectal cancer (mCRC): Lessons from a European study by Maravic, Z., Trenevski, J. Stanisic, Bokros, J., Casado, A. Ruiz, de Pedro, C. González, Otero, M. Méndez, Borràs, J., Ferro, T., Rial, O.

Get full text

Necrotising fasciitis in a patient treated with FOLFIRI-aflibercept for colorectal cancer: a case report by Gonzaga-López, A, Muñoz-Rodriguez, J, Ruiz-Casado, A

“…Anti-angiogenics have become an important part of the treatment of several types of tumours such as ovarian, breast, lung and colorectal cancer. Necrotising…”
Get full text

Geographic tongue induced by angiogenesis inhibitors by Ruiz-Casado, A, Gutiérrez, L, Sánchez, A, Manso, M

Get full text

AVEVAC: A phase I-II trial with avelumab plus autologous dendritic cell (ADC) vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer (mCRC) patients (GEMCAD 16-02) by Español Rego, M., Alonso, V., Aparicio, J., Elez Fernandez, E., Escudero, P., Fernández-Martos, C., Rodríguez, N., Ruiz Casado, A., Cid, J., Cabezón, R., Lozano, M., Ginés, A., Bianchi, L., Garcia-Corbacho, J., García de Albéniz, X., Maurel, J., Benitez Ribas, D.

Get full text

In the pathway to response: Is aflibercept an optimal treatment for RASwt mCRC patients after progression to 1st line containing anti-EGFR? by Mata Velasco, E, González-Flores, E, Juez Martel, I, Alonso, V, Iranzo Gomez, P, Martinez Lago, N, Lopez, C, Cabrera Romero, J M, Safont Aguilera, M J, Ruiz Casado, A, Salgado Fernandez, M, González Astorga, B, Escudero, P, Rivera Herrero, F, Pericay Pijaume, C, Vera, R

Get full text

Chemotherapy-induced enteritis: Institutional experience and review of the literature by Almagro Casado, E, Gutierrez, L, Sánchez Ruiz, A C, Ruiz Casado, A

Get full text

P-051Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA) by Pericay, C, Martinez-Lago, N, Corral, M, Macias Declara, I, Donnay, O, Juez Martel, I, Garcia-Paredes, B, Mendez Mendez, JC, Cacho Lanvin, D, Gonzalez-Astorga, B, Ruiz Casado, A, Delgado Urena, MT, Rodriguez, N, Calderero Aragon, V, Mata Velasco, E, Barrera Ramirez, JA, Macarulla, T

Get full text

P-145Metastases resection following FOLFIRI-aflibercept in refractory patients to first-line chemotherapy: safety and efficacy analysis by Munoz, A, Ruiz Casado, A, Pericay, C, Ibeas Millan, P, Grandez Ladron de Guevara, R, Diaz Pena, E, Lopez Munoz Ana, M, Gonzalez Cebrian, I, Moreno Santos Ma, A, Juez Martel, I, Encinas Garcia, S, Alcaide Garcia, J, Bruquetas, Machengs, Garcia Adrian, S, Lobo de Mena, M, Higuera, O, Ghanem, I, Garcia Alfonso, P, Rodriguez, N

Get full text

Progress in the clinical development of new marine-derived anticancer compounds by Jimeno, Jose, López-Martín, J. A, Ruiz-Casado, A, Izquierdo, M. A, Scheuer, P. J, Rinehart, K

“…Naturally derived anticancer agents continue to be instrumental in the systemic therapeutic intervention against solid tumors and hematological malignancies…”
Get full text

Pulmonary toxicity of 5-fluoracil and oxaliplatin by Ruiz-Casado, A, García, M D, Racionero, M A

Get full text

Geographic tongue induced by angiogenesis inhibitors by Ruiz-Casado, A, Gutiérrez, L, Sánchez, A, Manso, M

Get full text

1873P Cancer-related fatigue: Are we evaluating it? by Soriano Segura, M., Álvarez Bustos, A., Blanco Clemente, M., Salazar Mosteiro, C., Ruiz-Casado, A.

Get full text